Abstract:
HIV infection of B cells: Mechanisms of CD4-independent infection and unintegrated viral DNA

Title HIV infection of B cells: Mechanisms of CD4-independent infection and unintegrated viral DNA
Recipient

Surendra Sharma, MD, MBBS

Award Date 2000

Abstract

With a background of NIH-supported studies on B-cell lymphomas, this research represents a pilot study in HIV/AIDS for this investigator. Although B lymphocytes are a major constituents of lymphoid organs and acquire a significant altered phenotype and function in HIV-infected individuals, it remains unclear whether mostly CD4-negative B cells are susceptible fot viral entry and long term productive infection. This issue is of significance in the context of HIV-1 infection which is associated with both cellular and humoral deficiencies. During HIV infection, B cell disorders including polyclonal activation, hypergammaglobulinemia, and, most importantly, high-grade B cell lymphomas, occur frequently and result in humoral immunodeficiency. Although in vitro HIV-1 infection of B cells and cell surface trapping of HIV-1 by B cell CD21 receptor have been recently documented, the process of HIV-1 infection of B cells needs further clarification, in the context of long term productive infection, CD4-independent chemokine receptor usag , preference for naive or memory B cells, and oncogenic consequences.

Dr. Sharma's research objective has been to characterize B cell-derived HIV-1strains for genetic and functional alterations, establish ex-vivo HIV-1 infection of B cells using human tonsil explant infection system, assess the frequency of in vivo infected B cells in peripheral blood samples from HIV infected patients, and establish a possible link between the unintegrated viral genome and productive infection. Using CD4-negative Burkitt's lymphoma cell lines and normal naive and germinal center/memory tonsillar B cells, Dr. Sharma has recently demonstrated that HIV-1 strains can productively infect B cells in a CD4 independent but CXCR4 dependent manner. Furthermore, B cell-derived virus was found to be capable of infecting T cells and of inducing activation markers in B cells. A B cell clone derived from HIV-1-infected B cell line has been maintained for over 36 months with active HIV production. The viral genome in this clone predominantly exists in unintegrated linear and circular forms. This is inconsistent with the concept that a productive infection by HIV-1 is strictly a result of integrated proviruses. Dr. Sharma's HIV-related NIH funding is pending (R01 CA83517).